Contraceptive Drugs Market

Contraceptive Drugs Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

144

Base Year:

2022

Jun - 2022

Format:

Report Code:

VMR-1674

Segments Covered

By Product Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives
By Age Group 15–24 Years, 25–34 Years, 35–44 Years, Above 44 Years
By End User Homecare, Hospitals, Clinics
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2022
Forecast Years:	2023 - 2030
Historical Years:	2017 - 2021
Revenue 2022:	USD 12.62 Billion
Revenue 2030:	USD 18.94 Billion
Revenue CAGR (2023 - 2030):	5.20%
Fastest Growing Region (2023 - 2030)	Asia Pacific
Largest Region (2022):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Contraceptive Drugs Market - Segment Analysis
1. Overview
2. Global Contraceptive Drugs Market, 2016 - 2028 (USD Million)
3. Global Contraceptive Drugs Market - by Product
  1. By Oral Contraceptive Pills
  2. By Injectable Contraceptives
  3. By Topical Contraceptives
4. Global Contraceptive Drugs Market - by Age Group
  1. By 15–24 Years
  2. By 25–34 Years
  3. By 35–44 Years
  4. By Above 44 Years
5. Global Contraceptive Drugs Market - by End User
  1. By Homecare
  2. By Hospitals
  3. By Clinics
6. Global Contraceptive Drugs Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
7. Market comparative analysis
North America Contraceptive Drugs Market - Segment Analysis
1. Overview
2. North America Contraceptive Drugs Market, 2016 - 2028 (USD Million)
3. North America Contraceptive Drugs Market, by Product
  1. By Oral Contraceptive Pills
  2. By Injectable Contraceptives
  3. By Topical Contraceptives
4. North America Contraceptive Drugs Market, by Age Group
  1. By 15–24 Years
  2. By 25–34 Years
  3. By 35–44 Years
  4. By Above 44 Years
5. North America Contraceptive Drugs Market, by End User
  1. By Homecare
  2. By Hospitals
  3. By Clinics
6. North America Contraceptive Drugs Market, by Country
  1. U.S.
    1. U.S. Contraceptive Drugs Market, By Product
      1. By Oral Contraceptive Pills
      2. By Injectable Contraceptives
      3. By Topical Contraceptives
    2. U.S. Contraceptive Drugs Market, By Age Group
      1. By 15–24 Years
      2. By 25–34 Years
      3. By 35–44 Years
      4. By Above 44 Years
    3. U.S. Contraceptive Drugs Market, By End User
      1. By Homecare
      2. By Hospitals
      3. By Clinics
  2. Canada
    1. Canada Contraceptive Drugs Market, By Product
      1. By Oral Contraceptive Pills
      2. By Injectable Contraceptives
      3. By Topical Contraceptives
    2. Canada Contraceptive Drugs Market, By Age Group
      1. By 15–24 Years
      2. By 25–34 Years
      3. By 35–44 Years
      4. By Above 44 Years
    3. Canada Contraceptive Drugs Market, By End User
      1. By Homecare
      2. By Hospitals
      3. By Clinics
  3. Mexico
    1. Mexico Contraceptive Drugs Market, By Product
      1. By Oral Contraceptive Pills
      2. By Injectable Contraceptives
      3. By Topical Contraceptives
    2. Mexico Contraceptive Drugs Market, By Age Group
      1. By 15–24 Years
      2. By 25–34 Years
      3. By 35–44 Years
      4. By Above 44 Years
    3. Mexico Contraceptive Drugs Market, By End User
      1. By Homecare
      2. By Hospitals
      3. By Clinics
Europe Contraceptive Drugs Market - Segment Analysis
1. Overview
2. Europe Contraceptive Drugs Market, 2016 - 2028 (USD Million)
3. Europe Contraceptive Drugs Market, by Product
  1. By Oral Contraceptive Pills
  2. By Injectable Contraceptives
  3. By Topical Contraceptives
4. Europe Contraceptive Drugs Market, by Age Group
  1. By 15–24 Years
  2. By 25–34 Years
  3. By 35–44 Years
  4. By Above 44 Years
5. Europe Contraceptive Drugs Market, by End User
  1. By Homecare
  2. By Hospitals
  3. By Clinics
6. Europe Contraceptive Drugs Market, by Country
  1. Germany
    1. Germany Contraceptive Drugs Market, By Product
      1. By Oral Contraceptive Pills
      2. By Injectable Contraceptives
      3. By Topical Contraceptives
    2. Germany Contraceptive Drugs Market, By Age Group
      1. By 15–24 Years
      2. By 25–34 Years
      3. By 35–44 Years
      4. By Above 44 Years
    3. Germany Contraceptive Drugs Market, By End User
      1. By Homecare
      2. By Hospitals
      3. By Clinics
  2. UK
    1. UK Market, By Product
      1. By Oral Contraceptive Pills
      2. By Injectable Contraceptives
      3. By Topical Contraceptives
    2. UK Market, By Age Group
      1. By 15–24 Years
      2. By 25–34 Years
      3. By 35–44 Years
      4. By Above 44 Years
    3. UK Market, By End User
      1. By Homecare
      2. By Hospitals
      3. By Clinics
  3. France
    1. France Contraceptive Drugs Market, By Product
      1. By Oral Contraceptive Pills
      2. By Injectable Contraceptives
      3. By Topical Contraceptives
    2. France Contraceptive Drugs Market, By Age Group
      1. By 15–24 Years
      2. By 25–34 Years
      3. By 35–44 Years
      4. By Above 44 Years
    3. France Contraceptive Drugs Market, By End User
      1. By Homecare
      2. By Hospitals
      3. By Clinics
  4. Spain
    1. Spain Contraceptive Drugs Market, By Product
      1. By Oral Contraceptive Pills
      2. By Injectable Contraceptives
      3. By Topical Contraceptives
    2. Spain Contraceptive Drugs Market, By Age Group
      1. By 15–24 Years
      2. By 25–34 Years
      3. By 35–44 Years
      4. By Above 44 Years
    3. Spain Contraceptive Drugs Market, By End User
      1. By Homecare
      2. By Hospitals
      3. By Clinics
  5. Italy
    1. Italy Contraceptive Drugs Market, By Product
      1. By Oral Contraceptive Pills
      2. By Injectable Contraceptives
      3. By Topical Contraceptives
    2. Italy Contraceptive Drugs Market, By Age Group
      1. By 15–24 Years
      2. By 25–34 Years
      3. By 35–44 Years
      4. By Above 44 Years
    3. Italy Contraceptive Drugs Market, By End User
      1. By Homecare
      2. By Hospitals
      3. By Clinics
  6. BENELUX
    1. BENELUX Contraceptive Drugs Market, By Product
      1. By Oral Contraceptive Pills
      2. By Injectable Contraceptives
      3. By Topical Contraceptives
    2. BENELUX Contraceptive Drugs Market, By Age Group
      1. By 15–24 Years
      2. By 25–34 Years
      3. By 35–44 Years
      4. By Above 44 Years
    3. BENELUX Contraceptive Drugs Market, By End User
      1. By Homecare
      2. By Hospitals
      3. By Clinics
  7. Rest of Europe
    1. Rest Of Europe Contraceptive Drugs Market, By Product
      1. By Oral Contraceptive Pills
      2. By Injectable Contraceptives
      3. By Topical Contraceptives
    2. Rest Of Europe Contraceptive Drugs Market, By Age Group
      1. By 15–24 Years
      2. By 25–34 Years
      3. By 35–44 Years
      4. By Above 44 Years
    3. Rest Of Europe Contraceptive Drugs Market, By End User
      1. By Homecare
      2. By Hospitals
      3. By Clinics
Asia Pacific Contraceptive Drugs Market - Segment Analysis
1. Overview
2. Asia Pacific Contraceptive Drugs Market, 2016 - 2028 (USD Million)
3. Asia Pacific Contraceptive Drugs Market, by Product
  1. By Oral Contraceptive Pills
  2. By Injectable Contraceptives
  3. By Topical Contraceptives
4. Asia Pacific Contraceptive Drugs Market, by Age Group
  1. By 15–24 Years
  2. By 25–34 Years
  3. By 35–44 Years
  4. By Above 44 Years
5. Asia Pacific Contraceptive Drugs Market, by End User
  1. By Homecare
  2. By Hospitals
  3. By Clinics
6. Asia Pacific Contraceptive Drugs Market, by Country
  1. China
    1. China Contraceptive Drugs Market, By Product
      1. By Oral Contraceptive Pills
      2. By Injectable Contraceptives
      3. By Topical Contraceptives
    2. China Contraceptive Drugs Market, By Age Group
      1. By 15–24 Years
      2. By 25–34 Years
      3. By 35–44 Years
      4. By Above 44 Years
    3. China Contraceptive Drugs Market, By End User
      1. By Homecare
      2. By Hospitals
      3. By Clinics
  2. Japan
    1. Japan Contraceptive Drugs Market, By Product
      1. By Oral Contraceptive Pills
      2. By Injectable Contraceptives
      3. By Topical Contraceptives
    2. Japan Contraceptive Drugs Market, By Age Group
      1. By 15–24 Years
      2. By 25–34 Years
      3. By 35–44 Years
      4. By Above 44 Years
    3. Japan Contraceptive Drugs Market, By End User
      1. By Homecare
      2. By Hospitals
      3. By Clinics
  3. India
    1. India Contraceptive Drugs Market, By Product
      1. By Oral Contraceptive Pills
      2. By Injectable Contraceptives
      3. By Topical Contraceptives
    2. India Contraceptive Drugs Market, By Age Group
      1. By 15–24 Years
      2. By 25–34 Years
      3. By 35–44 Years
      4. By Above 44 Years
    3. India Contraceptive Drugs Market, By End User
      1. By Homecare
      2. By Hospitals
      3. By Clinics
  4. South Korea
    1. South Korea Contraceptive Drugs Market, By Product
      1. By Oral Contraceptive Pills
      2. By Injectable Contraceptives
      3. By Topical Contraceptives
    2. South Korea Contraceptive Drugs Market, By Age Group
      1. By 15–24 Years
      2. By 25–34 Years
      3. By 35–44 Years
      4. By Above 44 Years
    3. South Korea Contraceptive Drugs Market, By End User
      1. By Homecare
      2. By Hospitals
      3. By Clinics
  5. South East Asia
    1. South East Asia Contraceptive Drugs Market, By Product
      1. By Oral Contraceptive Pills
      2. By Injectable Contraceptives
      3. By Topical Contraceptives
    2. South East Asia Contraceptive Drugs Market, By Age Group
      1. By 15–24 Years
      2. By 25–34 Years
      3. By 35–44 Years
      4. By Above 44 Years
    3. South East Asia Contraceptive Drugs Market, By End User
      1. By Homecare
      2. By Hospitals
      3. By Clinics
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Contraceptive Drugs Market, By Product
      1. By Oral Contraceptive Pills
      2. By Injectable Contraceptives
      3. By Topical Contraceptives
    2. Rest of Asia Pacific Contraceptive Drugs Market, By Age Group
      1. By 15–24 Years
      2. By 25–34 Years
      3. By 35–44 Years
      4. By Above 44 Years
    3. Rest of Asia Pacific Contraceptive Drugs Market, By End User
      1. By Homecare
      2. By Hospitals
      3. By Clinics
Latin America Contraceptive Drugs Market - Segment Analysis
1. Overview
2. Latin America Contraceptive Drugs Market, 2016 - 2028 (USD Million)
3. Latin America Contraceptive Drugs Market, by Product
  1. By Oral Contraceptive Pills
  2. By Injectable Contraceptives
  3. By Topical Contraceptives
4. Latin America Contraceptive Drugs Market, by Age Group
  1. By 15–24 Years
  2. By 25–34 Years
  3. By 35–44 Years
  4. By Above 44 Years
5. Latin America Contraceptive Drugs Market, by End User
  1. By Homecare
  2. By Hospitals
  3. By Clinics
6. Latin America Contraceptive Drugs Market, by Country
  1. Brazil
    1. Brazil Contraceptive Drugs Market, By Product
      1. By Oral Contraceptive Pills
      2. By Injectable Contraceptives
      3. By Topical Contraceptives
    2. Brazil Contraceptive Drugs Market, By Age Group
      1. By 15–24 Years
      2. By 25–34 Years
      3. By 35–44 Years
      4. By Above 44 Years
    3. Brazil Contraceptive Drugs Market, By End User
      1. By Homecare
      2. By Hospitals
      3. By Clinics
  2. Argentina
    1. Argentina Contraceptive Drugs Market, By Product
      1. By Oral Contraceptive Pills
      2. By Injectable Contraceptives
      3. By Topical Contraceptives
    2. Argentina Contraceptive Drugs Market, By Age Group
      1. By 15–24 Years
      2. By 25–34 Years
      3. By 35–44 Years
      4. By Above 44 Years
    3. Argentina Contraceptive Drugs Market, By End User
      1. By Homecare
      2. By Hospitals
      3. By Clinics
  3. Rest of Latin America
    1. Rest of Latin America Contraceptive Drugs Market, By Product
      1. By Oral Contraceptive Pills
      2. By Injectable Contraceptives
      3. By Topical Contraceptives
    2. Rest of Latin America Contraceptive Drugs Market, By Age Group
      1. By 15–24 Years
      2. By 25–34 Years
      3. By 35–44 Years
      4. By Above 44 Years
    3. Rest of Latin America Contraceptive Drugs Market, By End User
      1. By Homecare
      2. By Hospitals
      3. By Clinics
Middle East & Africa Contraceptive Drugs Market - Segment Analysis
1. Overview
2. Middle East & Africa Contraceptive Drugs Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Contraceptive Drugs Market, by Product
  1. By Oral Contraceptive Pills
  2. By Injectable Contraceptives
  3. By Topical Contraceptives
4. Middle East & Africa Contraceptive Drugs Market, by Age Group
  1. By 15–24 Years
  2. By 25–34 Years
  3. By 35–44 Years
  4. By Above 44 Years
5. Middle East & Africa Contraceptive Drugs Market, by End User
  1. By Homecare
  2. By Hospitals
  3. By Clinics
6. Middle East & Africa Contraceptive Drugs Market, by Country
  1. GCC Countries
    1. GCC Countries Contraceptive Drugs Market, By Product
      1. By Oral Contraceptive Pills
      2. By Injectable Contraceptives
      3. By Topical Contraceptives
    2. GCC Countries Contraceptive Drugs Market, By Age Group
      1. By 15–24 Years
      2. By 25–34 Years
      3. By 35–44 Years
      4. By Above 44 Years
    3. GCC Countries Contraceptive Drugs Market, By End User
      1. By Homecare
      2. By Hospitals
      3. By Clinics
  2. South Africa
    1. South Africa Contraceptive Drugs Market, By Product
      1. By Oral Contraceptive Pills
      2. By Injectable Contraceptives
      3. By Topical Contraceptives
    2. South Africa Contraceptive Drugs Market, By Age Group
      1. By 15–24 Years
      2. By 25–34 Years
      3. By 35–44 Years
      4. By Above 44 Years
    3. South Africa Contraceptive Drugs Market, By End User
      1. By Homecare
      2. By Hospitals
      3. By Clinics
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Contraceptive Drugs Market, By Product
      1. By Oral Contraceptive Pills
      2. By Injectable Contraceptives
      3. By Topical Contraceptives
    2. Rest of Middle East & Africa Contraceptive Drugs Market, By Age Group
      1. By 15–24 Years
      2. By 25–34 Years
      3. By 35–44 Years
      4. By Above 44 Years
    3. Rest of Middle East & Africa Contraceptive Drugs Market, By End User
      1. By Homecare
      2. By Hospitals
      3. By Clinics
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Agile Therapeutics
2. Allergan PLC
3. Bayer AG
4. GlaxoSmithKline PLC
5. Johnson & Johnson
6. Piramal Healthcare
7. Mylan N.V.
8. Pfizer Inc.
9. Novartis AG
10. Teva Pharmaceutical Industries Ltd.
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

Vantage Market Research | 22-Jun-2022

Contraceptive Drugs Market to Reach Valuation of USD 16.5 Billion by 2028 – Increasing Awareness About Birth Control Drives the Market

FAQ

Frequently Asked Question

What is the global demand for Contraceptive Drugs in terms of revenue?

The global Contraceptive Drugs valued at USD 12.62 Billion in 2022 and is expected to reach USD 18.94 Billion in 2030 growing at a CAGR of 5.20%.

Which are the prominent players in the market?

The prominent players in the market are Agile Therapeutics, Allergan PLC, Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson, Piramal Healthcare, Mylan N.V., Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd..

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 5.20% between 2023 and 2030.

What are the driving factors fueling the growth of the market.

The driving factors of the Contraceptive Drugs include
- Rise in need for preventing unwanted pregnancy

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Contraceptive Drugs in 2022.

Contraceptive Drugs Market

Contraceptive Drugs Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Contraceptive Drugs in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Vantage Market Research

Products & Services

Media

Contact Us

Contraceptive Drugs Market

Contraceptive Drugs Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Contraceptive Drugs in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Contraceptive Drugs Market

Vantage Point Interactive Dashboard